ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 117 filers reported holding ARENA PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $139,000 | +189.6% | 95,400 | +183.1% | 0.01% | +116.7% |
| Q4 2016 | $48,000 | +4.3% | 33,700 | +27.2% | 0.01% | +20.0% |
| Q3 2016 | $46,000 | -41.8% | 26,500 | -42.8% | 0.01% | -54.5% |
| Q2 2016 | $79,000 | +154.8% | 46,300 | +196.8% | 0.01% | +175.0% |
| Q1 2016 | $31,000 | -55.7% | 15,600 | -57.6% | 0.00% | -63.6% |
| Q4 2015 | $70,000 | -11.4% | 36,800 | +62.1% | 0.01% | -8.3% |
| Q4 2014 | $79,000 | – | 22,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 867,700 | $5,085,000 | 1.68% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,369,066 | $25,603,000 | 1.03% |
| Lyons Wealth Management, LLC. | 56,775 | $334,000 | 0.30% |
| Callan Capital, LLC | 66,118 | $387,000 | 0.10% |
| QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 383,050 | $2,245,000 | 0.06% |
| FCG ADVISORS, LLC | 10,600 | $62,000 | 0.05% |
| OppenheimerFunds, Inc. | 7,000,000 | $41,020,000 | 0.04% |
| NEXT Financial Group, Inc | 19,704 | $86,000 | 0.04% |
| WELLINGTON MANAGEMENT GROUP LLP | 27,893,387 | $163,455,000 | 0.04% |
| MURPHY CAPITAL MANAGEMENT INC | 45,000 | $263,000 | 0.04% |